Skip to main content

ORIGINAL RESEARCH article

Front. Bioeng. Biotechnol.
Sec. Synthetic Biology
Volume 12 - 2024 | doi: 10.3389/fbioe.2024.1426107

GenoMine: a CRISPR-Cas9-based kill-switch for biocontainment of Pseudomonas putida

Provisionally accepted
  • 1 Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands
  • 2 Bioprocess Engineering Group, Wageningen University & Research, Wageningen, Netherlands
  • 3 LifeGlimmer GmbH, Berlin, Germany

The final, formatted version of the article will be published soon.

    Synthetic genetic circuits have revolutionised our capacity to control cell viability by conferring microorganisms with programmable functionalities to limit survival to specific environmental conditions. Here, we present the GenoMine safeguard, a CRISPR-Cas9-based kill switch for the biotechnological workhorse Pseudomonas putida that employs repetitive genomic elements as cleavage targets to unleash a highly genotoxic response. To regulate the system’s activation, we tested various circuit-based mechanisms including the digitalised version of an inducible expression system that operates at the transcriptional level and different options of post-transcriptional riboregulators. All of them were applied not only to directly control Cas9 and its lethal effects, but also to modulate the expression of two of its inhibitors: the AcrIIA4 anti-CRISPR protein and the transcriptional repressor TetR. Either upon direct induction of the endonuclease or under non-induced conditions of its inhibitors, the presence of Cas9 suppressed cell survival which could be exploited beyond biocontainment in situations where further CRISPR genome editing is undesirable.

    Keywords: CRISPR-Cas9-mediated biocontainment, Kill-switch, Riboregulator, Genetic circuit, P. putida

    Received: 01 May 2024; Accepted: 15 Aug 2024.

    Copyright: © 2024 Asin-Garcia, Martin-Pascual, de Buck, Allewijn, Müller and Martins Dos Santos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Enrique Asin-Garcia, Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands
    Vitor Martins Dos Santos, Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.